Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fabrizio Tonetto"'
Autor:
Giancarlo Marra, Federico Lesma, Gabriele Montefusco, Claudia Filippini, Jonathan Olivier, Andres Affentranger, Josias Bastian Grogg, Thomas Hermanns, Luca Afferi, Christian D. Fankhauser, Agostino Mattei, Bartosz Malkiewicz, Simone Scuderi, Francesco Barletta, Sebastian Gallina, Alessandro Antonelli, Fabio Zattoni, Fabrizio Dal Moro, Wever Lieke, Timo Soeterik, Roderick C.N. van den Bergh, Pawel Rajwa, Shahrokh F. Shariat, Lara Rodriguez-Sanchez, Rossella Nicoletti, Riccardo Campi, Mohamed Ahmed, R. Jeffrey Karnes, Michael Ladurner, Isabel Heidegger, Alberto Briganti, Paolo Gontero, Giorgio Gandaglia, William Berchiche, Guillaume Ploussard, Peter Chiu, Charles Dariane, Ignacio Puche-Sanz, Kamil Kowalczyk, Alberto Bianchi, Alessandro Magli, Fabrizio Tonetto, Matteo Facco
Publikováno v:
European Urology Open Science, Vol 68, Iss , Pp 32-39 (2024)
Background and objective: More than 10% of patients with negative clinical metastatic status (cN0M0) on conventional imaging for prostate cancer (PCa) harbor lymph node involvement (pN+) at final pathology following radical prostatectomy (RP) and lym
Externí odkaz:
https://doaj.org/article/aa25afd1ffd04a149f6639b62938aaeb
Autor:
Francesca Titone, Stefano Restaino, Eugenia Moretti, Gianluca Vullo, Alice Poli, Martina Arcieri, Chiara Paglietti, Fabrizio Tonetto, Giuseppe Parisi, Elisa Barbui, Marco Trovò, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIntermediate-high and high-risk endometrial cancer often require adjuvant treatments such as radiotherapy (RT) or brachitherapy (BT) to reduce the risk of loco-regional relapse. Inter- and intra-fraction variability of internal pelvic ana
Externí odkaz:
https://doaj.org/article/a61a20c32aea4fbe9c18c17c08dfa042
Autor:
ALESSANDRO MAGLI, MARCO LORENZO BONÙ, FABRIZIO TONETTO, EUGENIA MORETTI, GIOACCHINO DE GIORGI, LUIGI SPIAZZI, MARCO TROVÒ, DAVIDE TOMASINI, STEFANO MARIA MAGRINI, LUCA TRIGGIANI
Publikováno v:
In Vivo
Background/Aim: Stereotactic radiotherapy (SRT) is an effective treatment for localized prostate cancer. However, is it not clear whether the addition of androgen deprivation therapy (ADT) to SRT is beneficial. The aim of this study was to analyze th
Autor:
Fabrizio Tonetto, Alessandro Magli, Eugenia Moretti, Andrea Emanuele Guerini, Annarita Tullio, Chiara Reverberi, Tino Ceschia, Luigi Spiazzi, Francesca Titone, Agnese Prisco, Marco Andrea Signor, Michela Buglione, Gioacchino De Giorgi, Marco Trovò, Luca Triggiani
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 6913
Objective: This paper illustrates the results of a mono-institutional registry trial, aimed to test whether gastrointestinal (GI) and genitourinary (GU) toxicity rates were lower in localized prostate cancer patients treated with image-guided volumet
Autor:
Montserrat Pazos, René Baumann, Fabrizio Tonetto, Edwin Bölke, Christiane Matuschek, Rosario Mazzola, Filippo Alongi, Icro Meattini, Stefanie Corradini, Giulio Francolini, David Krug, Vanessa Figlia, Marco Trovo
The standard of care for early-stage breast cancer (BC) consists of breast-conserving surgery followed by postoperative irradiation. Recently, the concept of changing the usual sequence of treatment components in BC RT has been investigated. Potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65252a1b2e67ce814b0faf355d65c41f
http://hdl.handle.net/11379/526490
http://hdl.handle.net/11379/526490
Autor:
Annarita Tullio, Margherita Polsinelli, P Scalchi, C. Foti, Giulia Bravo, Gioacchino De Giorgi, Margherita Crespi, Gianluca Giannarini, Alessandro Magli, Fabrizio Tonetto, E. Moretti, Agnese Prisco, Marco Trovo, Mauro Urpis
Publikováno v:
Prostate cancer and prostatic diseases. 21(2)
The approach for treating high-risk prostate cancer still presents different unresolved issues. We report the safety and efficacy of a radiation therapy strategy based on the combination of moderate hypofractioned simultaneous integrated boost (SIB)
Autor:
Alessandro Magli, M.A. Signor, C.T. Sacco, E. Moretti, M.R. Malisan, M. Polsinelli, M. Guernieri, G. De Giorgi, Vincenzo Ficarra, T. Ceschia, C. Fontanella, Giuliana Parisi, A. Prisco, C. Foti, G. Chiaulon, M. Crespi, Fabrizio Tonetto
Publikováno v:
Radiotherapy and Oncology. 119
Autor:
Fabrizio Tonetto, Paola Del Bianco, Fabio Canova, Pierfranco Conte, Marco Schiavon, G. Zago, Federico Rea, Valentina Polo, Laura Bonanno, Giuseppe Marulli, Adolfo Favaretto, Giulia Pasello, L. Loreggian
Publikováno v:
OncoTargets and therapy
Laura Bonanno,1 Giulia Zago,1 Giuseppe Marulli,2 Paola Del Bianco,3 Marco Schiavon,2 Giulia Pasello,1 Valentina Polo,1,4 Fabio Canova,1 Fabrizio Tonetto,5 Lucio Loreggian,5 Federico Rea,2 PierFranco Conte,1,4 Adolfo Favaretto1 1Medical Oncology Unit
Autor:
Carla Loreto, Alessandro Marco Minisini, Fabio Puglisi, Fabrizio Tonetto, Pamela Driol, Giuseppe Damante, Mauro Mansutti, Piernicola Machin, Laura Deroma, Gianpiero Fasola, Claudia Andreetta, Stefania Russo, Manuela Miscoria
Publikováno v:
Anti-cancer drugs. 23(3)
The aim of the present study is to evaluate the clinical and biological factors (including markers of angiogenesis) as potential predictors of prognosis and benefit from metronomic therapy in patients with advanced breast cancer (ABC). Recent data su